UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

P.331 Brexpiprazole and aripiprazole for the adjunctive treatment of major depressive disorder: post hoc analysis of completion rates in long-term studies

European neuropsychopharmacology, 2020-11, Vol.40, p.S193-S194

2020

Volltextzugriff (PDF)

P.565 A post-hoc analysis of the effect of brexpiprazole on patient engagement in patients with schizophrenia

European neuropsychopharmacology, 2020-11, Vol.40, p.S319-S320

2020

Volltextzugriff (PDF)

Short-term efficacy of brexpiprazole in patients with schizophrenia with clinically relevant levels of negative symptoms

European neuropsychopharmacology, 2019, Vol.29, p.S424-S424

2019

Volltextzugriff (PDF)

Predictors of weight change after long-term treatment with brexpiprazole in schizophrenia

European neuropsychopharmacology, 2019, Vol.29, p.S116-S117

2019

Volltextzugriff (PDF)

Long-term efficacy of brexpiprazole in patients with schizophrenia with clinically relevant levels of negative symptoms

European neuropsychopharmacology, 2019, Vol.29, p.S426-S427

2019

Volltextzugriff (PDF)

PMH4 AN INDIRECT TREATMENT COMPARISON OF BREXPIPRAZOLE VERSUS LURASIDONE IN PATIENTS UNDERGOING ACUTE AND MAINTENANCE PHASE TREATMENT FOR SCHIZOPHRENIA

Value in health, 2019-05, Vol.22, p.S226-S226

2019

Volltextzugriff (PDF)

P.690 Impact of second-generation antipsychotic side effects on functioning from a schizophrenia patient perspective: European perspective of a global patient-centered survey

European neuropsychopharmacology, 2019-12, Vol.29, p.S466-S466

2019

Volltextzugriff (PDF)

Short- and long-term effects of brexpiprazole on functioning in adults with schizophrenia with or without agitation/hostility: post hoc analysis

Neuroscience Applied, 2023, Vol.2, p.103565, Article 103565

2023

Volltextzugriff (PDF)

Short- and long-term effects of brexpiprazole on functioning in adults with schizophrenia analysed by improvement in anxiety: post hoc analysis

Neuroscience Applied, 2023, Vol.2, p.103566, Article 103566

2023

Volltextzugriff (PDF)

Short- and long-term effects of brexpiprazole on anxiety in adults with schizophrenia: post hoc analysis

Neuroscience Applied, 2023, Vol.2, p.103568, Article 103568

2023

Volltextzugriff (PDF)

Exploring patient life engagement from the perspective of patients with schizophrenia: a study using patient interviews

Neuroscience Applied, 2023, Vol.2, p.103567, Article 103567

2023

Volltextzugriff (PDF)

Nuclear-organelle interactions: the immutans variegation mutant of Arabidopsis is plastid autonomous and impaired in carotenoid biosynthesis

The Plant journal : for cell and molecular biology, 1994-08, Vol.6 (2), p.161-175

1994

Volltextzugriff (PDF)

Change in positive symptoms with olanzapine compared to other antipsychotic agents

Schizophrenia research, 2000, Vol.41 (1), p.39-39

2000

Volltextzugriff (PDF)

Calming versus sedative effects of IM olanzapine in agitated patients

European psychiatry, 2002-05, Vol.17, p.104-105

2002

Volltextzugriff (PDF)

Change in extrapyramidal symptoms with olanzapine in comparison with other antipsychotic agents

European neuropsychopharmacology, 1999-09, Vol.9, p.294-294

1999

Volltextzugriff (PDF)

Change in extrapyramidal symptoms with olanzapine in comparison with other antipsychotic agents

Schizophrenia research, 2000, Vol.41 (1), p.192-192

2000

Volltextzugriff (PDF)

Treatment of negative symptoms with olanzapine in comparison with other novel antipsychotic agents

Schizophrenia research, 2000, Vol.41 (1), p.38-39

2000

Volltextzugriff (PDF)

Smooth and safe transition from intramuscular to oral olanzapine

European psychiatry, 2002-05, Vol.17, p.104-104

2002

Volltextzugriff (PDF)

Treatment of negative symptoms with olanzapine in comparison with other novel antipsychotic agents

European neuropsychopharmacology, 1999-09, Vol.9, p.292-292

1999

Volltextzugriff (PDF)

Change in positive symptoms with olanzapine compared to other antipsychotic agents

European neuropsychopharmacology, 1999-09, Vol.9, p.293-293

1999

Volltextzugriff (PDF)

Acute pulmonary lesions in sheep experimentally infected with bovine viral diarrhoea virus

Journal of comparative pathology, 1998-10, Vol.119 (3), p.277-292

1998

Volltextzugriff (PDF)

Intramuscular olanzapine: Efficacy and safety in acutely agitated patients with dementia

European neuropsychopharmacology, 2001, Vol.11, p.S323-S323

2001

Volltextzugriff (PDF)

Intramuscular olanzapine: Efficacy and safety in acutely agitated patients diagnosed with mania associated with bipolar disorder

European neuropsychopharmacology, 2001, Vol.11, p.S276-S277

2001

Volltextzugriff (PDF)

Olanzapine versus haloperidol in transitioning from intramuscular (IM) to oral therapy

European neuropsychopharmacology, 2001, Vol.11, p.S279-S279

2001

Volltextzugriff (PDF)

Parietal hyperactivity in delusions of alien control

NeuroImage (Orlando, Fla.), 1996-06, Vol.3 (3), p.S598-S598

1996

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(27)
Tagungsberichte
(1)

Sprache

Englisch
(28)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

P.331 Brexpiprazole and aripiprazole for the adjunctive treatment of major depressive disorder: post hoc analysis of completion rates in long-term studies

P.565 A post-hoc analysis of the effect of brexpiprazole on patient engagement in patients with schizophrenia

Short-term efficacy of brexpiprazole in patients with schizophrenia with clinically relevant levels of negative symptoms

Predictors of weight change after long-term treatment with brexpiprazole in schizophrenia

Long-term efficacy of brexpiprazole in patients with schizophrenia with clinically relevant levels of negative symptoms

PMH4 AN INDIRECT TREATMENT COMPARISON OF BREXPIPRAZOLE VERSUS LURASIDONE IN PATIENTS UNDERGOING ACUTE AND MAINTENANCE PHASE TREATMENT FOR SCHIZOPHRENIA

P.690 Impact of second-generation antipsychotic side effects on functioning from a schizophrenia patient perspective: European perspective of a global patient-centered survey

Short- and long-term effects of brexpiprazole on functioning in adults with schizophrenia with or without agitation/hostility: post hoc analysis

Short- and long-term effects of brexpiprazole on functioning in adults with schizophrenia analysed by improvement in anxiety: post hoc analysis

Short- and long-term effects of brexpiprazole on anxiety in adults with schizophrenia: post hoc analysis

Exploring patient life engagement from the perspective of patients with schizophrenia: a study using patient interviews

Nuclear-organelle interactions: the immutans variegation mutant of Arabidopsis is plastid autonomous and impaired in carotenoid biosynthesis

Change in positive symptoms with olanzapine compared to other antipsychotic agents

Calming versus sedative effects of IM olanzapine in agitated patients

Change in extrapyramidal symptoms with olanzapine in comparison with other antipsychotic agents

Change in extrapyramidal symptoms with olanzapine in comparison with other antipsychotic agents

Treatment of negative symptoms with olanzapine in comparison with other novel antipsychotic agents

Smooth and safe transition from intramuscular to oral olanzapine

Treatment of negative symptoms with olanzapine in comparison with other novel antipsychotic agents

Change in positive symptoms with olanzapine compared to other antipsychotic agents

Acute pulmonary lesions in sheep experimentally infected with bovine viral diarrhoea virus

Intramuscular olanzapine: Efficacy and safety in acutely agitated patients with dementia

Intramuscular olanzapine: Efficacy and safety in acutely agitated patients diagnosed with mania associated with bipolar disorder

Olanzapine versus haloperidol in transitioning from intramuscular (IM) to oral therapy

Parietal hyperactivity in delusions of alien control

Suchergebnisse filtern